Kalaris Therapeutics, Inc. (KLRS) - Latest Market Data

Price & Market Data

Price: $6.70

Daily Change: +$0.18 / 2.69%

Range: $6.50 - $6.86

Market Cap: $125,306,080

Volume: 13,382

Performance Metrics

1 Week: -4.15%

1 Month: -27.25%

3 Months: -33.73%

6 Months: -62.54%

1 Year: -63.17%

YTD: -30.64%

Company Details

Employees: 6

Sector: Health technology

Industry: Biotechnology

Country:

Details

Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.

Selected stocks

John B. Sanfilippo & Son, Inc. (JBSS)

The Vita Coco Company, Inc. (COCO)

Leggett & Platt, Incorporated (LEG)